University Of Nebraska
Clinical trials sponsored by University Of Nebraska, explained in plain language.
-
New pill may help myeloma patients stay in remission longer after transplant
Disease control OngoingThis study tests a drug called iberdomide as maintenance therapy for people with multiple myeloma who have had a stem cell transplant. The goal is to see if more patients can stay on treatment for at least a year without the disease getting worse. About 40 adults will take iberdo…
Phase: PHASE2 • Sponsor: University of Nebraska • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New drug may lessen painful side effects of anal cancer therapy
Disease control OngoingThis study tests a new drug called BMX-001 added to standard radiation and chemotherapy for people newly diagnosed with anal cancer. The goal is to see if BMX-001 can reduce severe side effects like rectal bleeding and skin problems while still fighting the cancer. About 24 adult…
Phase: PHASE1, PHASE2 • Sponsor: University of Nebraska • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Can acne drug or hormone shots help men with low sperm count?
Disease control ENROLLING_BY_INVITATIONThis study tests two treatments—isotretinoin (an acne medication) and hCG (a hormone)—to see if they can help men with low or no sperm count produce moving sperm. About 100 men aged 19 to 50 will take one of the drugs for three months. The goal is to find new options for male inf…
Phase: PHASE2 • Sponsor: University of Nebraska • Aim: Disease control
Last updated Jun 27, 2026 12:10 UTC
-
Promising brain tumor drug trial pulled before it started
Disease control TerminatedThis study planned to test an oral drug called ONC201 (dordaviprone) in people with a type of brain tumor called meningioma that had come back or was not responding to other treatments. One group would have taken the drug before surgery to see how much reached the tumor, and anot…
Phase: PHASE2 • Sponsor: University of Nebraska • Aim: Disease control
Last updated Jun 27, 2026 08:14 UTC
-
New drug combo aims to shrink breast tumors before surgery, spare chemo
Disease control OngoingThis phase II trial is testing whether giving the drug palbociclib (Ibrance) together with hormone therapy (letrozole, plus goserelin for premenopausal women) before surgery can shrink early-stage hormone receptor-positive, HER2-negative breast tumors. The study enrolls 51 patien…
Phase: PHASE2 • Sponsor: University of Nebraska • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Can a High-Tech patch help underserved diabetes patients control blood sugar?
Disease control ENROLLING_BY_INVITATIONThis study looks at whether a continuous glucose monitor (CGM) – a small sensor worn on the arm that checks blood sugar constantly – can help underserved patients with type 2 diabetes better manage their condition compared to traditional finger-stick testing. Fifty adults with po…
Phase: NA • Sponsor: University of Nebraska • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Can a quick radiation boost make CAR T-Cell therapy work better for lymphoma?
Disease control OngoingThis early-phase trial is testing whether giving low-dose radiation before CAR T-cell therapy is feasible and safe for people with B-cell lymphoma that has come back or not responded to treatment. About 33 participants will receive two small doses of radiation, then standard CAR …
Phase: PHASE1 • Sponsor: University of Nebraska • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Magic mushroom compound tested for cancer anxiety
Symptom relief OngoingThis early-stage study tests whether a single dose of psilocybin, the active ingredient in magic mushrooms, can reduce depression and anxiety in people with advanced pancreatic, biliary, or other gastrointestinal cancers. The study enrolls 24 adults aged 19-85 with stage IV or in…
Phase: PHASE1 • Sponsor: University of Nebraska • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
VR games could boost hand skills in kids with cerebral palsy
Symptom relief OngoingThis study looks at whether virtual reality games designed for hand-arm training can improve hand function in children with hemiplegic cerebral palsy. Seventeen children will either play VR games or do standard hand exercises for 40 hours over two weeks. Researchers will measure …
Phase: NA • Sponsor: University of Nebraska • Aim: Symptom relief
Last updated Jun 27, 2026 07:51 UTC
-
Could a simple spit test replace the dreaded deep nose swab?
Knowledge-focused OngoingThis study compares new, less invasive ways to collect samples for respiratory virus testing—like a nasal wash or saliva—against the standard deep nose swab. Researchers want to see if these gentler methods work just as well and cause less pain. About 1,000 adults in the emergenc…
Phase: NA • Sponsor: University of Nebraska • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC
-
Can a Twice-Monthly shot help rural patients stick with HIV treatment?
Knowledge-focused OngoingThis study looks at how well a long-acting HIV injection (CAB+RPV LA) works for people who live far from their doctor. About 55 patients and clinic staff will share their experiences through surveys and interviews over 15 months. The goal is to understand what helps or hinders ge…
Sponsor: University of Nebraska • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC
-
Brain training for wobbly ankles? new study hopes to personalize rehab
Knowledge-focused ENROLLING_BY_INVITATIONThis study from the University of Nebraska aims to understand why some people with chronic ankle instability have different problems—some have loose ligaments, others have poor brain control. Researchers will test 42 physically active adults, including healthy controls, people co…
Phase: NA • Sponsor: University of Nebraska • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC
-
New study tests opioid destruction bags to keep leftover pills out of wrong hands
Knowledge-focused OngoingThis study looks at how patients use and store opioid pain pills after knee or hip replacement surgery, and whether teaching them about safe destruction helps. About 163 adults will get a special handout and a Deterra bag to destroy leftover pills. Researchers will call them 6-8 …
Phase: NA • Sponsor: University of Nebraska • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
Walking study pulled before it even started
Knowledge-focused TerminatedThis study was designed to see if changing the sound of your own footsteps—by making them louder or softer—could affect how stable you are while walking. The researchers planned to test healthy adults who could walk for 30 minutes. However, the study was withdrawn before enrollin…
Phase: NA • Sponsor: University of Nebraska • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC